Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome

Giuseppe Zampino, Francesca Pantaleoni, Claudio Carta, Gilda Cobellis, Isabella Vasta, Cinzia Neri, Edgar A. Pogna, Emma De Feo, Angelica Delogu, Anna Sarkozy, Francesca Atzeri, Angelo Selicorni, Katherine A Rauen, Cheryl S. Cytrynbaum, Rosanna Weksberg, Bruno Dallapiccola, Andrea Ballabio, Bruce D. Gelb, Giovanni Neri, Marco Tartaglia

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS). To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene. A de novo heterozygous HRAS change was detected in all the subjects diagnosed with CS, while no lesion was observed with any of the other phenotypes. While eight cases shared the recurrent c.34G > A change, a novel c.436G > A transition was observed in one individual. The latter affected residue, p.Ala146, which contributes to guanosine triphosphate (GTP)/guanosine diphosphate (GDP) binding, defining a novel class of activating HRAS lesions that perturb development. Clinical characterization indicated that p.Gly12Ser was associated with a homogeneous phenotype. By analyzing the genomic region flanking the HRAS mutations, we traced the parental origin of lesions in nine informative families and demonstrated that de novo mutations were inherited from the father in all cases. We noted an advanced age at conception in unaffected fathers transmitting the mutation.

Original languageEnglish (US)
Pages (from-to)265-272
Number of pages8
JournalHuman Mutation
Volume28
Issue number3
DOIs
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Costello Syndrome
Mutation
Phenotype
Fathers
Noonan Syndrome
Germ-Line Mutation
Guanosine
Diphosphates
Guanosine Triphosphate
Oncogenes
Sarcoma
Genes

Keywords

  • Costello syndrome
  • HRAS
  • Mutation analysis
  • Parental origin of de novo mutations

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Zampino, G., Pantaleoni, F., Carta, C., Cobellis, G., Vasta, I., Neri, C., ... Tartaglia, M. (2007). Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. Human Mutation, 28(3), 265-272. https://doi.org/10.1002/humu.20431

Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. / Zampino, Giuseppe; Pantaleoni, Francesca; Carta, Claudio; Cobellis, Gilda; Vasta, Isabella; Neri, Cinzia; Pogna, Edgar A.; De Feo, Emma; Delogu, Angelica; Sarkozy, Anna; Atzeri, Francesca; Selicorni, Angelo; Rauen, Katherine A; Cytrynbaum, Cheryl S.; Weksberg, Rosanna; Dallapiccola, Bruno; Ballabio, Andrea; Gelb, Bruce D.; Neri, Giovanni; Tartaglia, Marco.

In: Human Mutation, Vol. 28, No. 3, 03.2007, p. 265-272.

Research output: Contribution to journalArticle

Zampino, G, Pantaleoni, F, Carta, C, Cobellis, G, Vasta, I, Neri, C, Pogna, EA, De Feo, E, Delogu, A, Sarkozy, A, Atzeri, F, Selicorni, A, Rauen, KA, Cytrynbaum, CS, Weksberg, R, Dallapiccola, B, Ballabio, A, Gelb, BD, Neri, G & Tartaglia, M 2007, 'Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome', Human Mutation, vol. 28, no. 3, pp. 265-272. https://doi.org/10.1002/humu.20431
Zampino, Giuseppe ; Pantaleoni, Francesca ; Carta, Claudio ; Cobellis, Gilda ; Vasta, Isabella ; Neri, Cinzia ; Pogna, Edgar A. ; De Feo, Emma ; Delogu, Angelica ; Sarkozy, Anna ; Atzeri, Francesca ; Selicorni, Angelo ; Rauen, Katherine A ; Cytrynbaum, Cheryl S. ; Weksberg, Rosanna ; Dallapiccola, Bruno ; Ballabio, Andrea ; Gelb, Bruce D. ; Neri, Giovanni ; Tartaglia, Marco. / Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. In: Human Mutation. 2007 ; Vol. 28, No. 3. pp. 265-272.
@article{fe0c76a68eed45bc8d21e07510758465,
title = "Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome",
abstract = "Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS). To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene. A de novo heterozygous HRAS change was detected in all the subjects diagnosed with CS, while no lesion was observed with any of the other phenotypes. While eight cases shared the recurrent c.34G > A change, a novel c.436G > A transition was observed in one individual. The latter affected residue, p.Ala146, which contributes to guanosine triphosphate (GTP)/guanosine diphosphate (GDP) binding, defining a novel class of activating HRAS lesions that perturb development. Clinical characterization indicated that p.Gly12Ser was associated with a homogeneous phenotype. By analyzing the genomic region flanking the HRAS mutations, we traced the parental origin of lesions in nine informative families and demonstrated that de novo mutations were inherited from the father in all cases. We noted an advanced age at conception in unaffected fathers transmitting the mutation.",
keywords = "Costello syndrome, HRAS, Mutation analysis, Parental origin of de novo mutations",
author = "Giuseppe Zampino and Francesca Pantaleoni and Claudio Carta and Gilda Cobellis and Isabella Vasta and Cinzia Neri and Pogna, {Edgar A.} and {De Feo}, Emma and Angelica Delogu and Anna Sarkozy and Francesca Atzeri and Angelo Selicorni and Rauen, {Katherine A} and Cytrynbaum, {Cheryl S.} and Rosanna Weksberg and Bruno Dallapiccola and Andrea Ballabio and Gelb, {Bruce D.} and Giovanni Neri and Marco Tartaglia",
year = "2007",
month = "3",
doi = "10.1002/humu.20431",
language = "English (US)",
volume = "28",
pages = "265--272",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome

AU - Zampino, Giuseppe

AU - Pantaleoni, Francesca

AU - Carta, Claudio

AU - Cobellis, Gilda

AU - Vasta, Isabella

AU - Neri, Cinzia

AU - Pogna, Edgar A.

AU - De Feo, Emma

AU - Delogu, Angelica

AU - Sarkozy, Anna

AU - Atzeri, Francesca

AU - Selicorni, Angelo

AU - Rauen, Katherine A

AU - Cytrynbaum, Cheryl S.

AU - Weksberg, Rosanna

AU - Dallapiccola, Bruno

AU - Ballabio, Andrea

AU - Gelb, Bruce D.

AU - Neri, Giovanni

AU - Tartaglia, Marco

PY - 2007/3

Y1 - 2007/3

N2 - Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS). To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene. A de novo heterozygous HRAS change was detected in all the subjects diagnosed with CS, while no lesion was observed with any of the other phenotypes. While eight cases shared the recurrent c.34G > A change, a novel c.436G > A transition was observed in one individual. The latter affected residue, p.Ala146, which contributes to guanosine triphosphate (GTP)/guanosine diphosphate (GDP) binding, defining a novel class of activating HRAS lesions that perturb development. Clinical characterization indicated that p.Gly12Ser was associated with a homogeneous phenotype. By analyzing the genomic region flanking the HRAS mutations, we traced the parental origin of lesions in nine informative families and demonstrated that de novo mutations were inherited from the father in all cases. We noted an advanced age at conception in unaffected fathers transmitting the mutation.

AB - Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS). To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity, subjects with a diagnosis of CS (N = 9), Noonan syndrome (NS; N = 36), cardiofaciocutaneous syndrome (CFCS; N = 4), or with a phenotype suggestive of these conditions but without a definitive diagnosis (N = 12) were screened for the entire coding sequence of the gene. A de novo heterozygous HRAS change was detected in all the subjects diagnosed with CS, while no lesion was observed with any of the other phenotypes. While eight cases shared the recurrent c.34G > A change, a novel c.436G > A transition was observed in one individual. The latter affected residue, p.Ala146, which contributes to guanosine triphosphate (GTP)/guanosine diphosphate (GDP) binding, defining a novel class of activating HRAS lesions that perturb development. Clinical characterization indicated that p.Gly12Ser was associated with a homogeneous phenotype. By analyzing the genomic region flanking the HRAS mutations, we traced the parental origin of lesions in nine informative families and demonstrated that de novo mutations were inherited from the father in all cases. We noted an advanced age at conception in unaffected fathers transmitting the mutation.

KW - Costello syndrome

KW - HRAS

KW - Mutation analysis

KW - Parental origin of de novo mutations

UR - http://www.scopus.com/inward/record.url?scp=33847211041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847211041&partnerID=8YFLogxK

U2 - 10.1002/humu.20431

DO - 10.1002/humu.20431

M3 - Article

VL - 28

SP - 265

EP - 272

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -